{"meshTags":["Clinical Trials as Topic","Cyclin-Dependent Kinase Inhibitor p16","Glioma","Humans","Mutation","Neoplasm Grading","Proto-Oncogene Proteins B-raf"],"meshMinor":["Clinical Trials as Topic","Cyclin-Dependent Kinase Inhibitor p16","Glioma","Humans","Mutation","Neoplasm Grading","Proto-Oncogene Proteins B-raf"],"genes":["BRAF","CDKN2A"],"publicationTypes":["News"],"title":"BRAF and CDKN2A mutations in secondary high-grade glioma.","pubmedId":"25818616"}